OncTimes Talk
By Oncology Times
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Oncology Times
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 100
Description
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
| Episode | Date |
|---|---|
|
Radioactive Resilience: A Survivor's Mission to Cure Cancer
|
Feb 02, 2026 |
|
Results from OncoExTra® Testing of 10K Tumor Samples Show the Next Generation of Sequencing
|
Jan 05, 2026 |
|
The Evolving Landscape of Bladder Cancer
|
Jan 02, 2026 |
|
The Current State of Skin Cancer in the U.S.
|
Dec 01, 2025 |
|
United Theranostics and the Future of Cancer Care
|
Nov 03, 2025 |
|
Smashing Plates, Facing Fear: Heather Von St. James' Journey
|
Oct 01, 2025 |
|
Joey-Rose Jester on Life with Cholangiocarcinoma: A Conversation About Cancer, Work, and Everything in Between
|
Sep 01, 2025 |
|
From Ironman to Advocate: Tom Hulsey's Journey Through Prostate Cancer and Purpose
|
Aug 01, 2025 |
|
Accurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test
|
Jul 17, 2025 |
|
Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield
|
Jul 01, 2025 |
|
Defying the Odds: Katie Colman's Journey from Diagnosis to Advocacy
|
Jun 02, 2025 |
|
Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing
|
May 28, 2025 |
|
Patient-Matched Tumor-Normal Sequencing: What It Is and Why It Matters
|
May 28, 2025 |
|
Transforming colorectal cancer management with tumor informed ctDNA testing
|
May 22, 2025 |
|
Lessons in Resilience: Dr. Susan MacDonald's Healthcare Journey
|
May 02, 2025 |
|
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities at High Risk
|
Mar 27, 2025 |
|
Episode 3, Better Informed Patient Journeys
|
Mar 05, 2025 |
|
Episode 2, HRD Testing Deep-Dive
|
Mar 05, 2025 |
|
Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer
|
Mar 05, 2025 |
|
Striking Microbiome Bacterial Population Differences Distinguish Metastatic Prostate Cancer From Non-Metastatic Disease
|
Mar 03, 2025 |
|
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer
|
Mar 03, 2025 |
|
Novel Score Selects Patients With Intermediate Risk Prostate Cancer Safe for Active Surveillance
|
Mar 03, 2025 |
|
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities
|
Mar 03, 2025 |
|
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
|
Jan 25, 2025 |
|
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
|
Jan 13, 2025 |
|
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
|
Jan 10, 2025 |
|
Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development
|
Jan 10, 2025 |
|
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
|
Jan 10, 2025 |
|
Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer
|
Jan 10, 2025 |
|
The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front
|
Dec 31, 2024 |
|
Digital Twin Brings AI Power to Individualize Cancer Management
|
Dec 25, 2024 |
|
Wnt Signaling Pathway Inhibitor Suggests Toxicity-Free Cure Potential for Hepatoblastoma
|
Dec 25, 2024 |
|
Anti-HER2 Combination Found Effective in HER2-Altered Bile Duct Cancers
|
Dec 12, 2024 |
|
FGFR-3 Inhibitor Has Early Clinical Activity in Advanced Urothelial Cancer
|
Nov 19, 2024 |
|
Radiation Delivery by Mini Protein Brings Promise for Metastatic Urothelial & Other Solid Tumors
|
Nov 15, 2024 |
|
Antibody-Drug Conjugate "Promising Efficacy" in HER2-Positive and HER2-Low Breast Cancer
|
Nov 15, 2024 |
|
Advanced Melanoma: CheckMate 067 10-Year Data Show Prognoses Transformed By Checkpoint Inhibitors
|
Oct 30, 2024 |
|
Preoperative Chemoradiation Ruled Out for Gastric or GE Junction Resectable Adenocarcinoma
|
Oct 30, 2024 |
|
Perioperative Checkpoint Inhibition Better for Muscle-Invasive Bladder Cancer
|
Oct 30, 2024 |
|
Recurrent Glioma: Encouraging Responses to Autologous Myeloid Dendritic Cell Therapy
|
Oct 30, 2024 |
|
Therapeutic mRNA Vaccine Brings New Hope in Glioblastoma
|
Oct 23, 2024 |
|
Resectable Stage III Melanoma: Unprecedented Survival Benefit With Pure Checkpoint Inhibitor Neoadjuvant Therapy
|
Oct 23, 2024 |
|
Circulating Tumor DNA Directs Precision Management for Ovarian Cancer
|
Oct 15, 2024 |
|
ESMO Reports Neoadjuvant Therapy for TNBC, Combination Checkpoint Inhibition, Artificial Intelligence & More
|
Oct 14, 2024 |
|
Cardio-Oncology: Many Cancer Treatment Cardiotoxicities Still to Be Understood
|
Oct 14, 2024 |
|
Emerging Potential for Cell Therapies in Ovarian Cancer and Other Solid Tumors
|
Oct 07, 2024 |
|
Global Cooperation on Antibody-Drug Conjugates: Key Driver of Progress in HER2-Dependent Metastatic Breast Cancer Treatment
|
Oct 07, 2024 |
|
World-Wide Clinical Perspectives from Chinese Society of Clinical Oncology's Globally Upscale 2024 Annual Meeting
|
Oct 04, 2024 |
|
Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer
|
Oct 04, 2024 |
|
Breastfeeding is Safe After Treatment for BRCA-Positive Breast Cancer
|
Sep 27, 2024 |
|
Breastfeeding After Hormone Receptor-Positive Breast Cancer: No Detectable Risk for Patients
|
Sep 26, 2024 |
|
Findings at ESMO 2024 Highlighting the Benefit of Neoadjuvant Therapies
|
Sep 26, 2024 |
|
HPV Vaccination Prevents HIV-Related Cancers in Men
|
Jul 10, 2024 |
|
Proton Pump Inhibitors Bigger Impact on Dasatinib Efficacy in CML Than Previously Thought
|
Jul 09, 2024 |
|
Immune-Related Adverse Events Predict Response to Checkpoint Inhibitor Monotherapy in Advanced Head & Neck Cancers
|
Jul 09, 2024 |
|
A Multi-Drug Algorithm Used to Accurately Predict Best First-Line Treatments in Patients With Newly Diagnosed Acute Myeloid Leukemia
|
Jul 09, 2024 |
|
MUC-1 Vaccine Delays Breast Cancer Distant Recurrence & Extends Survival
|
Jun 25, 2024 |
|
Telehealth Triumphs for Palliative Care Delivery in Patients With Lung Cancer
|
Jun 25, 2024 |
|
Lymphadenectomy Can Be Safely Omitted for Patients With Advanced Epithelial Ovarian Cancer Lacking Suspicious Lymph Nodes
|
Jun 25, 2024 |
|
Neoadjuvant Checkpoint Inhibitor Combination Beats Standard Surgery With Adjuvant Immunotherapy in Macroscopic, Resectable Stage III Melanoma
|
Jun 25, 2024 |
|
Asciminib May Be a Safer, More Effective Treatment for Patients With Newly Diagnosed Chronic Myeloid Leukemia
|
Jun 19, 2024 |
|
Chemotherapy Before and After Surgery Improved Outcomes for Patients With Resectable Locally Advanced Esophageal Adenocarcinoma
|
Jun 18, 2024 |
|
Trastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine Therapy
|
Jun 18, 2024 |
|
Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC
|
Jun 11, 2024 |
|
Study Finds Durvalumab Improved Progression-Free and Overall Survival in Limited Stage Small Cell Lung Cancer
|
Jun 11, 2024 |
|
German Study Finds New Regimen for Hodgkin Lymphoma More Effective, Less Toxic
|
Jun 11, 2024 |
|
Kinase Inhibitor Delivers Synthetic Lethality to Enhance Radiotherapy in Glioblastoma
|
May 29, 2024 |
|
mRNA Vaccine + Checkpoint Inhibitor Combo Had Low Toxicity With Evidence of Efficacy in Advanced NSCLC
|
May 29, 2024 |
|
Earliest Detection of Cancer by Artificial Intelligence Analysis of Circulating Cell-Free DNA Fragmentomes
|
May 29, 2024 |
|
Clinical Study Shows Selective PARP 1 Inhibitor More Effective, Less Toxic
|
May 15, 2024 |
|
Exercise Deters Prostate Cancer Death & Progression
|
May 15, 2024 |
|
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers
|
May 15, 2024 |
|
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma
|
May 02, 2024 |
|
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection
|
May 02, 2024 |
|
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers
|
May 02, 2024 |
|
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery
|
Apr 26, 2024 |
|
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed
|
Apr 26, 2024 |
|
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain
|
Apr 24, 2024 |
|
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection
|
Apr 24, 2024 |
|
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer
|
Apr 12, 2024 |
|
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
|
Apr 11, 2024 |
|
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema
|
Apr 11, 2024 |
|
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes
|
Apr 11, 2024 |
|
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab
|
Mar 27, 2024 |
|
Triple Therapy for Patients With Mutated FLT3 Gene in Acute Myeloid Leukemia
|
Mar 22, 2024 |
|
Important Mantle Cell Lymphoma Findings From the Sympatico Study
|
Mar 12, 2024 |
|
World's Largest Prostate Cancer Trial, STAMPEDE, Celebrates 20 Years of Progress
|
Mar 06, 2024 |
|
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
|
Mar 04, 2024 |
|
Gene-Targeted Agent Brings Clinical Benefit in R/R Acute Leukemias
|
Feb 29, 2024 |
|
INTERLACE Study Boosts Cervical Cancer Survival
|
Feb 28, 2024 |
|
RET Fusion-Targeted Drug Doubles Progression-Free Survival in NSCLC Patients
|
Feb 16, 2024 |
|
Afatinib Recommended for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations
|
Feb 16, 2024 |
|
Adjuvant Radiotherapy No Benefit After Radical Prostatectomy
|
Feb 14, 2024 |
|
Collagen-Bound Interleukin 12 Converts "Cold" Tumors Into "Hot" Ones
|
Feb 14, 2024 |
|
Allogeneic Transplant for AML: Only in Patients Negative for Molecular Minimum Residual Disease
|
Feb 07, 2024 |
|
Antibody-Drug Conjugate Brings Success in High-Risk R/R Follicular Lymphoma
|
Feb 06, 2024 |
|
Pirtobrutinib After Covalent BTK Inhibitor - Double Refractory CLL
|
Jan 18, 2024 |
|
Relapsed or Refractory CLL - With Sameer A. Parikh, MBBS, and Alessandra Ferrajoli, MD
|
Jan 17, 2024 |
|
CLL Frontline Treatment - With Sameer A. Parikh, MBBS, & Alessandra Ferrajoli, MD
|
Jan 16, 2024 |
|
Sabestomig in Non-Small Cell Lung Cancer: Bi-Specific Antibody Safe and Active
|
Nov 30, 2023 |